GBV-C: state of the art and future prospects (Q34247167)

31 July 2017

GBV-C: state of the art and future prospects (English)

1 reference

31 July 2017

Esper Georges Kallas

2

0 references

author name string

Maria Teresa Maidana Giret

series ordinal

1

1 reference

31 July 2017

1 March 2012

1 reference

31 July 2017

Current HIV/AIDS reports

1 reference

31 July 2017

9

1 reference

31 July 2017

1

1 reference

31 July 2017

26-33

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0109-1

31 July 2017

0 references

cites work

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

2 references

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

21 January 2018

12 December 2020

Isolation of novel virus-like sequences associated with human hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

The natural history of non-human GB virus C in captive chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

A new genotype 2 subcluster identified among GBV-C strains circulating in the Lisbon metropolitan area of Portugal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Diagnostic value of anti-GBV-C antibodies in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Infection with GB virus C and reduced mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Effect of coinfection with GB virus C on survival among patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Persistent GB virus C infection and survival in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Frequency and genotype of GB virus C among Iranian patients infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus type C infection modulates T-cell activation independently of HIV-1 viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Analysis of GB virus C infection among HIV-HCV coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Characterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Fluorescence study of the dynamic interaction between E1(145-162) sequence of hepatitis GB virus C and liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

GB virus type C interactions with HIV: the role of envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0109-1

Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.

21 January 2018

1 reference

12 December 2020

Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide

1 reference

12 December 2020

Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles

1 reference

12 December 2020

Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure

1 reference

12 December 2020

Detection of hepatitis G virus envelope protein E2 antibody in blood donors.

1 reference

12 December 2020

10.1007/S11904-011-0109-1

Identifiers

DOI

1 reference

PubMed ID

22246585

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

22246585